Halama, Niels <br/><br/>
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.  [electronic resource] 

 -  Cancer cell  Apr 2016 
 - 587-601 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccell.2016.03.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Apoptosis--drug effects<br/>Chemokine CCL5--antagonists & inhibitors<br/>Chemokines--physiology<br/>Chemotaxis<br/>Clinical Trials, Phase I as Topic<br/>Clodronic Acid--pharmacology<br/>Colorectal Neoplasms--immunology<br/>Cyclohexanes--pharmacology<br/>Humans<br/>Interferon-alpha--metabolism<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Macrophages--drug effects<br/>Maraviroc<br/>Molecular Targeted Therapy<br/>NG-Nitroarginine Methyl Ester--pharmacology<br/>Neoplasm Invasiveness<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Phenylurea Compounds--therapeutic use<br/>Pilot Projects<br/>Pyridines--therapeutic use<br/>Receptors, CCR5--drug effects<br/>STAT3 Transcription Factor--physiology<br/>Survival Analysis<br/>Triazoles--pharmacology<br/>Tumor Cells, Cultured<br/>Tumor Microenvironment--drug effects